top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Biogen's $6.5B Acquisition of Reata: Powering Up Rare Disease Portfolio!

Cambridge, MA, July 28, 2023 (Reuters) -- Biogen (BIIB.O) has announced that it is acquiring Reata Pharmaceuticals (RETA.O), for almost $6.5 billion. This marks the first significant acquisition under the leadership of CEO Christopher Viehbacher, steering the drugmaker towards a path of growth.


Read full article here.

Recent Posts

See All

Opmerkingen


Life Science Headlines

© 2024 by Jacobs Management Group, Inc.

​

Privacy Policy

​

bottom of page